BioHive
Founded 2023 · 13 employees on LinkedIn · 3 known investors
BioHive develops skin organoid technology derived from iPSCs, offering customizable organoids with multiple cell types for toxicity, efficacy, and inflammatory analysis. It serves the pharmaceutical and dermo-cosmetic industries to reduce R&D costs and reliance on animal models.
Founders & leadership
BioHive was founded in 2023 by Giulia and Cesare.
G
GiuliaCo-founder
C
CesareCo-founder
C
Cécile
Investors · 3
Frequently asked questions
- What does BioHive do?
- BioHive develops skin organoid technology derived from iPSCs, offering customizable organoids with multiple cell types for toxicity, efficacy, and inflammatory analysis. It serves the pharmaceutical and dermo-cosmetic industries to reduce R&D costs and reliance on animal models.
- Who founded BioHive?
- BioHive was founded by Giulia, Cesare in 2023.
- Who are BioHive's investors?
- BioHive's investors include 50 Partners, Kima Ventures, Teampact.ventures.